Confirmed Control Announced Transaction verified Consumer HealthCPGDietary SupplementsNutraceuticalsVitaminsVitamins & Supplements

Atrium Innovations acquired by Nestlé

Nestlé agreed to acquire Atrium Innovations, a vitamins & supplements brand, on Dec 5, 2017.

Transaction summary

Target
Atrium Innovations
Acquirer
Nestlé
Seller
-
Announced
2017-12-05
Geography
-
Tags
Consumer HealthCPGDietary SupplementsNutraceuticalsVitaminsVitamins & Supplements
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-06-19

Value and multiples

100% enterprise value

USD 2.3B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

3.3x

Period not stated

Basis: FundComb estimate

EV / EBITDA

19x

EBITDA basis not stated

Basis: FundComb estimate

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: USD 2.3B

$2.3 billion headline value reported in Google News results/snippets from Reuters, WSJ, and New Hope Network; full articles were not fetched.

Basis

  • USD 2.3bn consideration is treated as publicly disclosed or derived directly from public source data.
  • Valuation covers 100% of the target; the amount invested or paid for a stake is separate.
  • EV / revenue: 3.3x.
  • Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.

Source summary

No public source summary has been published for this transaction yet.